Paul K Olson
Summary
I am the President and co-founder of Kypha, a company dedicated to the diagnosis, treatment and monitoring of inflammatory disease. Lupus, severe trauma, and stroke are our lead indications. I am also a co-founder and former Chief Scientific Officer of Potentia Pharmaceuticals, the first company to enter clinical trials with a complement inhibitor for the treatment of age-related macular degeneration,
Biotechnology Genetics Immunology Ophthalmology Pharmacology Radiology & Medical Imaging Rheumatology